Clinical trial
A Multi-arm, Adaptive, Group-sequential Trial NETwork to Evaluate Drug Efficacy in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT06008249 is registered in ClinicalTrials.gov with Stichting TRICALS Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-arm, Adaptive, Group-sequential Trial NETwork to Evaluate Drug Efficacy in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Stichting TRICALS Foundation
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 9, 2021
- Completion date
- September 1, 2025
- Enrollment
- 88 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.